Skip to main content

Vividion Therapeutics, Inc. is a biopharmaceutical company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a deep and diversified pipeline of highly selective small molecule therapeutics targeting high value disease-causing proteins in oncology and immunology.

Contact
Alicia Davis
THRUST Strategic Communications
alicia@thrustsc.com